INMUNOTEK is an application developed with the aim of providing healthcare professionals with a unique digital tool that gathers the most relevant information about the new immunotherapy based on manno-conjugated allergoids directed to dendritic cells.
Through this application, health professionals can access the most outstanding scientific publications and additional training materials, which allow them to be updated in this new treatment. The application is available in three languages (Spanish, English and Portuguese).
In INMUNOTEK you will find:
- An explanatory video of the mechanism of action of these vaccines.
- A compilation of scientific articles published as support for this new immunotherapy.
- A presentation through augmented reality of the interaction of the allergoid-mannan complexes with the dendritic cells, detailing each of the phases of this process.
Inmunotek is a pharmaceutical laboratory based in Madrid, founded in 1992, which researches, develops, manufactures and markets products for the diagnosis and treatment of diseases in the field of allergy and immunology, both for human and veterinary pathology.
It has its own R + D + I department, where 15% of the annual profits are invested, with high-level researchers who develop their activity in various research projects, technological development and innovation. Our motto Innovamos y Compartimos Ideas is the commitment to a dynamic research and open to collaboration with other groups and companies. Inmunotek is identified as an innovative company appearing in the public register of Innovative SMEs of the General Directorate of Innovation and Competitiveness of the Ministry of Economy and Competitiveness.
Through this application, health professionals can access the most outstanding scientific publications and additional training materials, which allow them to be updated in this new treatment. The application is available in three languages (Spanish, English and Portuguese).
In INMUNOTEK you will find:
- An explanatory video of the mechanism of action of these vaccines.
- A compilation of scientific articles published as support for this new immunotherapy.
- A presentation through augmented reality of the interaction of the allergoid-mannan complexes with the dendritic cells, detailing each of the phases of this process.
Inmunotek is a pharmaceutical laboratory based in Madrid, founded in 1992, which researches, develops, manufactures and markets products for the diagnosis and treatment of diseases in the field of allergy and immunology, both for human and veterinary pathology.
It has its own R + D + I department, where 15% of the annual profits are invested, with high-level researchers who develop their activity in various research projects, technological development and innovation. Our motto Innovamos y Compartimos Ideas is the commitment to a dynamic research and open to collaboration with other groups and companies. Inmunotek is identified as an innovative company appearing in the public register of Innovative SMEs of the General Directorate of Innovation and Competitiveness of the Ministry of Economy and Competitiveness.
Show More
